Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $849.19 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $154.68 | 1 | $0 (2021) |
| Abbott Laboratories | $134.50 | 1 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $119.32 | 1 | $0 (2019) |
| Lilly USA, LLC | $116.64 | 1 | $0 (2022) |
| Amgen Inc. | $113.42 | 1 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $99.95 | 1 | $0 (2017) |
| Genentech USA, Inc. | $96.22 | 1 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.46 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $14.46 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($14.46) |
| 2022 | $251.14 | 2 | Abbott Laboratories ($134.50) |
| 2021 | $154.68 | 1 | Merz Pharmaceuticals, LLC ($154.68) |
| 2019 | $215.54 | 2 | Teva Pharmaceuticals USA, Inc. ($119.32) |
| 2018 | $113.42 | 1 | Amgen Inc. ($113.42) |
| 2017 | $99.95 | 1 | Otsuka America Pharmaceutical, Inc. ($99.95) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ICLUSIG (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: ONCOLOGY | ||||||
| 12/07/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $134.50 | General |
| Category: Neuromodulation | ||||||
| 07/26/2022 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | Cash or cash equivalent | $116.64 | General |
| Category: Neuroscience | ||||||
| 06/28/2021 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $154.68 | General |
| Category: Musculoskeletal | ||||||
| 11/20/2019 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $96.22 | General |
| 05/01/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $119.32 | General |
| Category: Central Nervous System | ||||||
| 05/31/2018 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $113.42 | General |
| Category: Neuroscience | ||||||
| 05/31/2017 | Otsuka America Pharmaceutical, Inc. | — | Food and Beverage | In-kind items and services | $99.95 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 98 | 268 | $39,665 | $18,917 |
| 2022 | 3 | 117 | 328 | $50,010 | $23,102 |
| 2021 | 3 | 115 | 390 | $53,361 | $23,838 |
| 2020 | 3 | 128 | 393 | $57,717 | $28,384 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 40 | 206 | $24,018 | $12,282 | 51.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 25 | $8,185 | $3,125 | 38.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 22 | $4,866 | $2,166 | 44.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 15 | 15 | $2,596 | $1,344 | 51.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 56 | 259 | $30,197 | $13,851 | 45.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 43 | 51 | $16,698 | $7,794 | 46.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 18 | 18 | $3,115 | $1,457 | 46.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 63 | 335 | $39,058 | $17,475 | 44.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 28 | 31 | $10,150 | $4,479 | 44.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 24 | 24 | $4,154 | $1,884 | 45.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 63 | 319 | $37,192 | $18,344 | 49.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 42 | 50 | $16,371 | $7,991 | 48.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 23 | 24 | $4,154 | $2,049 | 49.3% |
About Dr. Priya Sreedharan, M.D
Dr. Priya Sreedharan, M.D is a Physical Medicine & Rehabilitation healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740392380.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Priya Sreedharan, M.D has received a total of $849.19 in payments from pharmaceutical and medical device companies, with $14.46 received in 2023. These payments were reported across 8 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($849.19).
As a Medicare-enrolled provider, Sreedharan has provided services to 458 Medicare beneficiaries, totaling 1,379 services with total Medicare billing of $94,241. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Rochester, NY
- Active Since 08/31/2006
- Last Updated 09/22/2009
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1740392380
Products in Payments
- Xeomin (Biological) $154.68
- PROCLAIM (Device) $134.50
- AJOVY (Drug) $119.32
- EMGALITY (Drug) $116.64
- Aimovig (Biological) $113.42
- ICLUSIG (Drug) $14.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Rochester
Dr. Jonathan Finnoff, Do, DO
Physical Medicine & Rehabilitation — Payments: $12,810
Gabriel Smith, Md, MD
Physical Medicine & Rehabilitation — Payments: $7,192
Simer Preet Singh, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $6,016
Dr. Sandra Ogletree, Md, MD
Physical Medicine & Rehabilitation — Payments: $3,848
Dr. Brennan Boettcher, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $3,745
Geraldine Dapul, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $3,715